Latest Ratios: P/E Ratio 11.7x · EV/EBITDA 8.5x · ROE 11.5%. (1996–2025 historical series)
Price-based multiples — how expensive the stock is relative to earnings, sales, book value, and cash flow
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Market Cap | $24.8B | $27.4B | $22.5B | $19.0B | $17.9B | $17.0B | $14.3B | $15.9B | $14.5B | $16.0B | $12.7B |
| Enterprise Value | $25.1B | $27.7B | $24.0B | $19.6B | $17.9B | $17.9B | $13.6B | $16.4B | $15.1B | $16.6B | $13.2B |
| P/E Ratio → | 11.70 | 12.70 | 8.66 | 9.66 | — | 6.99 | 18.57 | 8.86 | — | 44.14 | 28.93 |
| P/S Ratio | 1.49 | 1.65 | 1.34 | 1.21 | 1.51 | 1.32 | 1.48 | 1.67 | 2.08 | 2.63 | 2.27 |
| P/B Ratio | 1.32 | 1.43 | 1.29 | 1.22 | 1.30 | 1.12 | 1.09 | 1.41 | 1.56 | 1.65 | 1.49 |
| P/FCF | 9.70 | 10.71 | 9.62 | 7.51 | 7.29 | 8.00 | 8.73 | 13.79 | 18.38 | 20.35 | 27.04 |
| P/OCF | 8.97 | 9.91 | 8.68 | 6.82 | 6.60 | 7.49 | 8.22 | 12.45 | 16.19 | 18.58 | 23.82 |
P/E links to full P/E history page with 30-year chart
Enterprise-value multiples — capital-structure-neutral measures of total business value
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| EV / Revenue | — | 1.67 | 1.43 | 1.25 | 1.51 | 1.38 | 1.41 | 1.72 | 2.17 | 2.73 | 2.36 |
| EV / EBITDA | 8.55 | 9.43 | 6.02 | 6.60 | 113.11 | 5.16 | 10.39 | 6.41 | 68.48 | 56.85 | 16.05 |
| EV / EBIT | 9.19 | 9.43 | 6.24 | 6.92 | 401.33 | 5.39 | 11.54 | 6.66 | 102.94 | 75.33 | 17.40 |
| EV / FCF | — | 10.85 | 10.25 | 7.77 | 7.27 | 8.40 | 8.31 | 14.23 | 19.16 | 21.12 | 28.08 |
Margins and return-on-capital ratios measuring operating efficiency
Full margin charts and quarterly trend are on the Earnings History page
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 69.4% | 69.4% | 55.4% | 51.4% | 28.8% | 45.6% | 35.1% | 51.0% | 38.1% | 30.4% | 42.1% |
| Operating Margin | 16.5% | 16.5% | 21.7% | 16.9% | -1.3% | 24.2% | 10.4% | 24.0% | -0.1% | 1.4% | 11.2% |
| Net Profit Margin | 12.7% | 12.7% | 16.4% | 12.7% | -1.8% | 18.8% | 8.5% | 18.8% | -1.8% | 6.5% | 8.1% |
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| ROE | 11.5% | 11.5% | 16.7% | 13.6% | -1.5% | 17.1% | 6.7% | 17.4% | -1.4% | 4.3% | 5.5% |
| ROA | 3.6% | 3.6% | 6.1% | 4.3% | -0.4% | 5.9% | 2.5% | 6.2% | -0.5% | 1.5% | 1.9% |
| ROIC | 10.7% | 10.7% | 15.6% | 13.3% | -0.8% | 16.5% | 6.2% | 15.8% | -0.1% | 0.7% | 5.9% |
| ROCE | 14.9% | 14.9% | 8.0% | 5.7% | -0.7% | 18.2% | 3.1% | 7.9% | -0.0% | 0.4% | 2.9% |
Solvency and debt-coverage ratios — lower is generally safer
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Debt / Equity | 0.23 | 0.23 | 0.32 | 0.32 | 0.30 | 0.32 | 0.35 | 0.36 | 0.32 | 0.32 | 0.30 |
| Debt / EBITDA | 1.46 | 1.46 | 1.42 | 1.67 | 25.99 | 1.39 | 3.46 | 1.57 | 13.68 | 10.64 | 3.12 |
| Net Debt / Equity | — | 0.02 | 0.08 | 0.04 | -0.00 | 0.06 | -0.05 | 0.05 | 0.07 | 0.06 | 0.06 |
| Net Debt / EBITDA | 0.12 | 0.12 | 0.37 | 0.21 | -0.21 | 0.24 | -0.53 | 0.20 | 2.79 | 2.06 | 0.59 |
| Debt / FCF | — | 0.13 | 0.62 | 0.25 | -0.01 | 0.40 | -0.42 | 0.44 | 0.78 | 0.76 | 1.04 |
| Interest Coverage | 14.27 | 14.27 | 18.81 | 15.34 | 0.23 | 18.05 | 6.63 | 14.31 | 0.95 | 1.66 | 5.85 |
Short-term solvency ratios and asset-utilisation metrics
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 0.84 | 0.84 | — | — | 1.18 | 1.27 | — | — | 0.69 | 0.77 | 1.41 |
| Quick Ratio | 0.84 | 0.84 | — | — | 1.18 | 1.27 | — | — | 0.63 | 5.08 | 9.64 |
| Cash Ratio | 0.28 | 0.28 | — | — | 0.66 | 0.76 | — | — | 0.44 | 0.51 | 0.93 |
| Asset Turnover | — | 0.24 | 0.35 | 0.36 | 0.24 | 0.27 | 0.28 | 0.31 | 0.26 | 0.22 | 0.23 |
| Inventory Turnover | — | — | — | — | — | — | — | — | — | — | — |
| Days Sales Outstanding | — | — | — | — | — | — | — | — | — | — | — |
Earnings, FCF, buyback, and dividend yields — total returns to shareholders
Full dividend history and growth charts are on the Dividend History page
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Dividend Yield | 2.5% | 2.3% | 0.2% | 0.2% | 0.2% | 0.2% | 0.1% | — | — | — | — |
| Payout Ratio | — | — | — | — | — | — | — | — | — | — | — |
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Earnings Yield | 8.5% | 7.9% | 11.5% | 10.4% | — | 14.3% | 5.4% | 11.3% | — | 2.3% | 3.5% |
| FCF Yield | 10.3% | 9.3% | 10.4% | 13.3% | 13.7% | 12.5% | 11.5% | 7.3% | 5.4% | 4.9% | 3.7% |
| Buyback Yield | 1.7% | 1.6% | 2.5% | 2.3% | 1.6% | 1.2% | 0.2% | 0.7% | 0.4% | 0.7% | 0.4% |
| Total Shareholder Yield | 4.2% | 3.8% | 2.7% | 2.5% | 1.8% | 1.4% | 0.3% | 0.7% | 0.4% | 0.7% | 0.4% |
| Shares Outstanding | — | $13M | $13M | $13M | $14M | $14M | $14M | $14M | $14M | $14M | $14M |
Underwriting volatility and social inflation
As reported in recent financial statements, Markel's P/B ratio of 1.28 suggests that the market is applying a significant discount to the firm's book value, likely reflecting investor skepticism regarding the scalability of the Ventures model amidst the recent deterioration in core underwriting profitability.
The current P/B multiple appears to indicate that the market is struggling to reconcile the value of the insurance float with the cyclical volatility of the Markel Ventures segment. Investors should monitor whether this discount persists as the firm attempts to pivot toward more stable, capital-light fee income streams.
According to quarterly data, the combined ratio spiked to 107.7% in 2026Q1, a sharp departure from the 73.2% observed in 2024Q3, which suggests that the firm's underwriting engine is currently struggling to maintain profitability in the face of heightened loss activity and persistent social inflation.
The rapid deterioration in the combined ratio indicates that the firm's specialty lines are experiencing significant pressure, potentially undermining the 'free float' advantage that historically supported the investment portfolio. This trend warrants further investigation into whether current pricing actions are sufficient to offset the rising loss costs.
Based on the provided figures, Markel's ROE fell to -1.1% in 2026Q1, down from a peak of 6.4% in 2024Q1, highlighting a significant erosion in profitability that appears to be driven primarily by the recent failure of the insurance segment to generate consistent underwriting margins.
The decline in ROE suggests that the firm's three-engine architecture is currently failing to deliver the expected returns, as underwriting losses are now offsetting the contributions from the investment portfolio and Ventures segment. This performance shift may indicate that the firm's historical reliance on underwriting discipline is being tested by current market conditions.
As reported in regulatory filings, the firm's D/E ratio has fluctuated, reaching 0.24 in 2026Q1, which, when viewed alongside the significant expansion in total liabilities to $50.0 billion, suggests that the company is increasingly utilizing financial leverage to support its diverse and growing operational footprint.
While the current leverage levels may appear manageable in isolation, the combination of rising liabilities and deteriorating underwriting performance suggests a narrowing margin of safety. Investors should monitor whether this increased leverage is being deployed effectively to generate long-term value or if it is merely masking underlying operational weaknesses.
As indicated by the firm's complex structure, the P/E ratio is frequently misapplied to Markel, as it fails to account for the massive unrealized gains and losses in the equity portfolio that are required to be recognized in the income statement under current accounting rules.
Using P/E to value Markel obscures the true underlying health of the insurance and Ventures operations by introducing significant, non-operational earnings volatility. Analysts should instead prioritize P/B as the primary valuation anchor, as it better reflects the capital base backing the insurance reserves and the long-term value of the Ventures holdings.
Includes 30+ ratios · 30 years · Updated daily
DCF models, multiple analysis, and analyst estimates.
10-year return with dividends reinvested.
See how regular investing compounds over time.
Compare growth, multiples, and margins vs sector.
Quick answers to the most common questions about buying MKL stock.
Markel Corporation's current P/E ratio is 11.7x. The historical average is 19.0x. This places it at the 20th percentile of its historical range.
Markel Corporation's current EV/EBITDA is 8.5x. This enterprise value multiple compares the company's total value (equity + debt - cash) to its EBITDA. The historical average is 15.1x.
Markel Corporation's return on equity (ROE) is 11.5%. The historical average is 8.0%.
Based on historical data, Markel Corporation is trading at a P/E of 11.7x. This is at the 20th percentile of its historical P/E range. Compare with industry peers and growth rates for a complete picture.
Markel Corporation's current dividend yield is 2.45%.
Markel Corporation has 69.4% gross margin and 16.5% operating margin. Operating margin between 10-20% is typical for established companies.
Markel Corporation's Debt/EBITDA ratio is 1.5x, indicating moderate leverage. A ratio below 2x is generally considered financially healthy.